Molecularly-targeted and biological anti-cancer therapy
Klener, P.; Klener, P.
Folia Biologica 58(1): 1-6
2012
ISSN/ISBN: 0015-5500 PMID: 22464818 Document Number: 661418
Document emailed within 1 workday
Related Documents
Tirelli, U.; Berretta, M.; Bearz, A.; Carbone, A. 2011: Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis European Review for Medical and Pharmacological Sciences 15(11): 1355-1356Janjigian, Y.Y.; Shah, M.A. 2011: Molecularly targeted therapies in advanced gastric cancer Minerva Gastroenterologica E Dietologica 57(1): 75-88
Saito, Y.; Gemma, A. 2011: Interstitial lung disease associated with chemotherapy and molecularly-targeted drug: diagnosis and management Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2531-2537
McKinnon, C. 1999: Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents Idrugs: the Investigational Drugs Journal 2(7): 624-628
Torres Salazar, A.; Hoheisel, J.; Youns, M.; Wink, M. 2011: Anti-inflammatory and anti-cancer activities of essential oils and their biological constituents International Journal of Clinical Pharmacology and Therapeutics 49(1): 93-95
Rajabi, M.; Adeyeye, M.; Mousa, S.A. 2019: Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer Current Medicinal Chemistry 26(30): 5664-5683
Tu, S.-M.; Lin, S.-H.; Podoloff, D.A.; Logothetis, C.J. 2010: Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer Clinical Advances in Hematology and Oncology: H&o 8(5): 341-351
Hwang, J.; Marshall, J.L. 2006: Targeted therapy for colorectal cancer Current Opinion in Investigational Drugs 7(12): 1062-1066
Rajpal, S.; Venook, A.P. 2006: Targeted therapy in colorectal cancer Clinical Advances in Hematology and Oncology: H&o 4(2): 124-132
Tongyoo, A. 2010: Targeted therapy: novel agents against cancer Journal of the Medical Association of Thailand 93(Suppl 7): S311-S323
Wcisło, G. 2008: Molecular underpinnings of the targeted therapy for cancer Acta Poloniae Pharmaceutica 65(6): 633-640
Henderson, I.C. 2012: Targeted therapy: a sea change in the treatment of cancer Oncology 26(11): 1035; 1039
Nonomura, N.; Nakayama, M.; Takayama, H.; Nishimura, K.; Okuyama, A. 2008: Molecular-targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 63-66
Hashimoto, Y.; Naruyama, H.; Ando, R.; Okada, S.; Tozawa, K.; Kohri, K. 2008: Molecular targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 57-61
Ikeda, S. 2013: Economic evaluation of targeted cancer therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(8): 967-970
Yano, S. 2013: Cancer targeted therapy and resistance signals SEIKAGAKU. Journal of Japanese Biochemical Society 85(6): 475-483
Ristimäki, A.; Kytölä, S.; Haglund, C.; Bono, P. 2013: Targeted therapy of a cancer patient is multiprofessional collaboration Duodecim; Laaketieteellinen Aikakauskirja 129(10): 1071-1079
Herbst, R.S. 2002: Targeted therapy in non-small-cell lung cancer Oncology 16(9 Suppl 9: 19-24
Jerzak, K.J.; Raphael, J.; Desautels, D.N.; Blanchette, P.S.; Tyono, I.; Pritchard, K.I. 2018: Bone-Targeted Therapy in Early Breast Cancer Oncology 32(11): 562-569
Kang, N.; Forcello, N. 2015: Targeted Cancer Therapy: Class Related Toxicities Connecticut Medicine 79(2): 109-113